Dietary and nutritional supplements for the treatment and prevention of viral and bacterial infections, respiratory distress, inflammation, and autoimmunity diseases; Pharmaceutical preparations for the treatment and prevention of viral and bacterial infections, respiratory distress, inflammation, and autoimmunity diseases

Pharmaceutical products for the treatment of retinal diseases

Research and development services and clinical trials in the field of retinal diseases

Pharmaceutical preparations, both prescription and natural health products, namely, anti-infectives; pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders being major depressive disorder (MDD), mood disorder, schizophrenia, Attention deficit hyperactivity disorder (ADHD), myasthenia gravis, Alzheimer's, Huntington's Disease, muscular dystrophy, cerebral palsy, for the treatment of eating disorders and addictions; pharmaceutical preparations for the prevention and treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the cardiovascular system being angina, for endocrine diseases and disorders being glucagonoma, short bowel syndrome, and growth and thyroid disorders, for metabolic diseases and disorders being diabetes, gout, arthritis and anemia, obesity, hyperlipidemia, insulin resistance, and metabolic syndrome; pharmaceutical preparations for the prevention and treatment of blood disorders; pharmaceuticals preparations for dermatology being antimicrobials and for the treatment of bacterial skin infections, eczema and psoriasis; pharmaceutical preparations for immunological disorders being Lambert-Eaton Myasthenic Syndrome (LEMS), vitamin products being vitamin and mineral supplements

Development of pharmaceutical preparations and medicines; pharmaceutical research and development

Pharmaceutical preparations for the treatment of gastrointestinal related diseases, disorders and infections

Pharmaceutical research and development

Research and development in the field of pharmaceuticals, nutraceuticals, and nutritional supplements; Research and development in the pharmaceutical and biotechnology fields

Meals.

Pharmaceutical preparations.

Dietetic food supplements, namely, hemp-based food supplements; food supplements, namely, herbal food supplements for general health and well-being; medicinal herbs, namely, dried cannabis buds for medical purposes; medicinal herb infusions, namely, mixed herbal infusions for maintaining normal blood pressure and heart function and reducing cholesterol; medicinal herbal extracts, namely, cannabis extracts for medical purposes; dietary and nutritional supplements, namely, nutritional supplements containing cannabis for medicinal purposes; dietary food supplements , namely, dietary food supplements for humans containing cannabis for medicinal purposes; medicated candy, namely, gummy vitamins containing cannabinoids for medicinal purposes; medicinal drinks, namely, cannabis-infused drinks for medical purposes; plant and herb extracts for medical purposes for use as a food additive, namely, cannabis extracts for medical purposes for use as a food additive; dietetic substances, namely, dietetic substances adapted for medical use containing cannabinoids; pharmaceutical preparations, namely, human pharmaceutical preparations for the relief of pain and the treatment of psychiatric disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses, and the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy; medical, medicated and therapeutic foodstuff additives, beverages and supplements, namely, nutritional additives for medical purposes namely for promoting general health and well-being, used in foods and dietary supplements for human consumption; non-medical and non-medicated foodstuff additives and supplements, namely, dietary food supplements in the nature of ready-to-eat protein bars, not for medical purposes; food and beverages for medical, medicinal, therapeutic and nutritional purposes, namely, dietetic food adapted for medical use containing cannabis; elixirs, namely, dietary supplement drink mixes for general health and wellbeing; tinctures for medicinal purposes, namely, medical cannabis in the form of tinctures that facilitate the delivery of drugs

Pharmaceutical and veterinary preparations and substances for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type II diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; pharmaceutical preparations and substances for the treatment of epilepsy; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical preparations and substances for the treatment of convulsions, seizures, Dravet syndrome, Lennox-Gastaut syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures, generalized epilepsy with febrile seizures plus, Doose syndrome and chromosome disorders; herbs for medicinal purposes, namely for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type ll diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; medicinal herbs for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type II diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; medicinal oils for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type ll diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; medicinal infusions for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and posttraumatic stress disorder, type ll diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxicischemic encephalopathy; medicinal infusions for the treatment of epilepsy, convulsions and seizures; pure extracts of medicinal plants and herbs for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and posttraumatic stress disorder, type II diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxicischemic encephalopathy; foodstuffs for medicinal purposes, namely, plant oil for the treatment of neurological diseases and conditions such as epilepsy and paediatric epilepsy, oncology, psychiatric disorders such as mood disorders and schizophrenia, type II diabetes, inflammation, cancer pain, multiple sclerosis spasticity and neonatal hypoxic-ischemic encephalopathy; dietary supplements for humans and animals, namely for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type II diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; dietetic food and substances adapted for medical and veterinary use containing cannabinoids; food for babies; herb teas for medicinal purposes, namely for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and posttraumatic stress disorder, type II diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxicischemic encephalopathy; medications for the treatment of multiple sclerosis, pain associated with cancer, neuropathies and rheumatoid arthritis; medicines for the treatment of symptoms namely, pain, muscle spasticity and spasms, bladder problems and sleep disorders; medications for the treatment of conditions to which neuropathic pain is associated, namely, multiple sclerosis, cancer, spinal cord injury, physical trauma and peripheral neuropathy resulting from diabetes; medicines for the treatment of anorexia-cachexia, the result of cancer and AIDS, and nausea, and secondary vomiting due to chemotherapy treatments.

Agricultural and horticultural products, namely, cannabis seeds for agricultural and horticultural purposes; agricultural seeds; seedlings for plant breeding; live flowers; live plants; plant residues, namely, cannabinoid oil for animal consumption, not medicinal; fresh herbs; foodstuffs and beverage for animals containing cannabinoids, not medicinal.

Pharmaceutical and medicated preparations, namely, for use in dermatology, namely, dermatitis, eczema, psoriasis, fungal infections, gastroenterology, rheumatology, and for use in the treatment of psychiatric disorders, namely, depression, mood disorders, anxiety disorders, cognitive disorders, post-traumatic stress disorders, obsessive-compulsive disorder, premenstrual dysphoric disorder, schizophrenia and bipolar disorders; pharmaceutical and medicated preparations, namely, for use in nephrology, neurology, namely, vasomotor disorders, disorders associated with thermoregulation, and disorders associated with improper neuronal signaling, oncology, urology, andrology and cardiology, and for use in the treatment of nasal allergies, respiratory allergies, pain and inflammation, and for use as anti-infectives; pharmaceutical preparations and substances directed to women's health for use in the treatment, alleviation and prevention of thermoregulatory dysfunctions and vasomotor symptoms in the nature of hot flashes, hot flushes, night awakenings, night sweats, and such disorders and conditions associated with perimenopause, menopause and hormonal deficiencies; menstrual symptom treatment preparations; contraceptive preparations; dietary supplements for general health and well-being; prenatal vitamins; pharmaceutical products for the treatment of bone diseases; preparations for the suppression of hormones; pharmaceutical preparations and substances directed to women's health for use in the treatment, alleviation and prevention of overactive bladder, female sexual dysfunction, infertility, endometriosis, vaginitis, osteoporosis, osteopenia, pelvic pain, dyspareunia, and candidiasis

Contraceptive devices, namely, contraceptive coils, intrauterine devices

Pharmaceutical preparations for the treatment of various diseases, namely, rare metabolic, endocrine, cardiac, oncological, gastrointestinal, nephrological, autoimmune, and neurological diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare metabolic, endocrine, cardiac, oncological, gastrointestinal, nephrological, autoimmune, and neurological diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical compounds in the form of a molecular nanoparticle complex that act as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies.

Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development for the treatment of various diseases, namely rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and cancers and viral infections; scientific investigations in the fields of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and cancers and viral infections for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials.